Friday, 17 June 2016

Alcove-project

  • Home
  • Aims
    • Context
    • Means
    • Objectives
  • Partners
    • Member States
    • Workpackage Leaders
    • All Partners
  • 4 Core questions
    • Epidemiological dataon dementia
      • Executive Summary
      • Recommendations
    • Timely diagnosisof Dementia
      • Executive Summary
      • Full Final Report
      • References
    • Rights, Autonomy & Dignityof people living with Dementia
      • Executive Summary
      • Recommendations
    • Support Systemsfor BPSD
      • Executive Summary
      • Recommendations
  • ALCOVE in progress
    • Alcove methods
      • Alcove procedures
  • Communication
    • Flyers and Posters
    • Slides
    • Pictures
    • Reports
    • Newsletters
    • Press Releases
    • ALCOVE IN VARIOUS LANGUAGES
  • Glossary
  • TOOLBOX
  • News and Events
    • Alcove News

ETHICS IN PRACTICE & ANTIPSYCHOTICS

ethic-in-practiceThe use of AP must be analyzed from several ethical perspectives: e.g. distinguishing situations where AP are used in response to particular symptoms & where they are as a form of restraint (as an alternative to physical restraint).

 

Ethical aspects of the use of antipsychotics in dementia

What do we know about AP& competence assesment?

Key Points and Tools

To know more

TOOLBOX

  • Home
  • Rationale
  • Antipsychotics Risk Measurement in Europe
  • Antipsychotics Risk Reduction
  • Timely Diagnosis & Antipsychotics
  • Ethics in practice & Antipsychotics
    • Ethical aspects of the use of antipsychotics in dementia
    • What do we know about AP & Competence assesment?
    • Key Points & Tools
  • Behavioural & Psychological Symtoms of Dementia
  • All the Tools
  • ALCOVE Glossary

ALCOVE has received funding from the European Commission in the framework of the Public Health Programme.
Grant Agreement N°2010 22 01

logo EU